Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by Redbaron2211on Aug 10, 2020 12:35pm

150 Views

Post# 31387957

RE:RE:RE:RE:Echelon on Sernova 4 August 2020

I wouldn't worry about Bio. He is just scrambling to buy back shares as he thought a PP was coming.

Consolidation is narrowing into a tighter and tighter range. This falling wedge is primed for a break out with some positive news on trials or collaboration. If there is no PP it's seems pretty obvious they are feeling good about locking up some $ in a collaboration.

Now couple that with the TSX-V currently in a breakout this could get juicy real quick.

GL

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal